Small-cap value investing has drawn renewed attention in recent market cycles as investors search for alternatives to large-cap growth concentration. AVUV and XSVM both target the same broad corner of the market — U.S. small-cap value stocks — yet they do so through markedly different lenses. One is an actively managed, deeply diversified portfolio built on value and profitability screens; the other is a passive index fund that combines value with momentum. Understanding their structural differences matters for anyone evaluating sector exposure, relative positioning, and cost efficiency within a small-cap value sleeve.
Launched in September 2019 by Avantis Investors, an affiliate of American Century, AVUV is an actively managed, rules-based exchange-traded fund (ETF) that seeks long-term capital appreciation. It holds roughly 770–800 small-cap U.S. companies selected for what the manager identifies as low valuations combined with higher profitability ratios, helping it avoid deeply unprofitable firms that often populate the value universe. I also checked this using Tickeron’s AI Screener to see how the holdings compare to others in the industry.
The portfolio is highly diversified, with the top 10 holdings representing only about 8–9% of assets. Representative names include Matson, GATX, Lantheus, Macy's, Five Below, Viasat, Lear, and Avnet. Sector allocation leans toward financial services (about 27%), consumer cyclical (about 19%), energy (about 16%), and industrials (about 12%). Its expense ratio is 0.25%, low for an active small-cap value fund, and its weighting methodology rebalances systematically as valuation and profitability characteristics shift.
Launched in March 2005, XSVM is a passively managed fund sponsored by Invesco that tracks the S&P 600 High Momentum Value Index. The index selects roughly 120 securities from the S&P SmallCap 600 universe that combine the strongest value scores with momentum scores, effectively screening for inexpensive stocks that are also exhibiting positive price trends.
The fund is noticeably more concentrated, with about 116–121 holdings and the top 10 positions accounting for roughly 14–16% of assets. Notable holdings include Kohl's, Lincoln National, MarineMax, StoneX Group, Sally Beauty, and Genworth Financial. Financials dominate the sector mix at roughly 45–50%, followed by consumer discretionary (about 18%), real estate (about 9%), and energy (about 6–7%). Its expense ratio is 0.37%, higher than AVUV but broadly in line with its category.
Both funds sit squarely in the U.S. small-cap value segment, a category sensitive to interest-rate expectations, credit conditions, and the health of regional banks and cyclical industries. In recent market cycles, a debate has intensified between mega-cap technology concentration and the cheaper valuations available among smaller, more economically sensitive companies. Financials — a dominant theme in both funds — remain tied to the interest-rate path and net interest margins, while energy and consumer-discretionary holdings respond to commodity trends and household spending. A steepening or falling yield curve, shifts in bank regulation, and merger-and-acquisition (M&A) activity among small firms are all catalysts that can reshape relative positioning in this space.
In recent weeks and months, small-cap value has experienced meaningful rotation alongside shifting rate expectations and a broadening of market leadership away from large-cap growth. XSVM's heavier financials weighting and its momentum overlay can amplify upside during strong cyclical upswings but also heighten volatility, while its concentration raises single-stock and single-sector risk. AVUV's broader footprint, profitability filter, and more balanced sector spread have historically produced smoother relative positioning with competitive long-term returns. Fund performance in this category tends to track earnings cycles among top holdings, credit spreads, and the trajectory of policy rates rather than any single daily move. From what I see, this distinction becomes especially relevant when evaluating longer-term risk-adjusted outcomes.
In my own analysis, I often turn to Tickeron’s AI-powered tools to cross-check structural details like holdings overlap and sector tilts. The AI Screener helps surface comparable ideas quickly by applying filters for market cap, value metrics, and momentum signals, allowing for a more efficient side-by-side review of funds like these without manual data crunching. It has become a regular part of how I refine ETF selections in the small-cap space.
Based on observable structural factors, Tickeron's AI would likely favor AVUV. Its lower expense ratio, far greater diversification across roughly 800 holdings, and disciplined profitability screens offer a more robust quality profile. While XSVM's momentum overlay can generate bursts of outperformance during strong cyclical rallies, its concentrated financials exposure and higher concentration risk make it a more tactical, higher-volatility vehicle. For investors seeking durable, cost-efficient small-cap value exposure with better risk distribution, AVUV presents the stronger probabilistic case. I’m watching this closely as rate expectations continue to evolve.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
XSVM moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend. In 40 of 44 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where XSVM's RSI Oscillator exited the oversold zone, 22 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on XSVM as a result. In 74 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for XSVM just turned positive on October 06, 2026. Looking at past instances where XSVM's MACD turned positive, the stock continued to rise in 41 of 49 cases over the following month. The odds of a continued upward trend are 84%.
The 10-day moving average for XSVM crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.
Following a +0.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where XSVM advanced for three days, in 253 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Aroon Indicator entered an Uptrend today. In 229 of 283 cases where XSVM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XSVM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
XSVM broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category SmallValue